A morphological study of the action of equine anti-lipopolysaccharide plasma on gram-negative bacteria

References

1. Bayer M E. 1967; Responses of cell walls of Escherichia coli to sudden reduction of environmental osmotic pressure. Journal of Bacteriology 93:1104–1112
   [Google Scholar]
2. Bayer M E, Remsen C C. 1970; Structure of Escherichia coli after freeze-etching. Journal of Bacteriology 101:304–313
   [Google Scholar]
3. Fine J. 1964; Septic shock. Journal of the American Medical Association 188:427–432
   [Google Scholar]
4. Gaffin S L, Badsha N, Vorster B J, Conradie J D, Brock-Utne J G. 1982a; An ELISA procedure for detecting human anti-endotoxin antibodies in serum. Annals of Clinical Biochemistry 19:191–194
   [Google Scholar]
5. Gaffin S L, Grinberg Z, Abraham C, Birkham J, Schechter Y. 1981a; Protection against hemorrhagic shock in the cat by human plasma containing endotoxin-specific antibodies. Journal of Surgical Research 31:18–21
   [Google Scholar]
6. Gaffin S L. 1981b; Antibiotic effect of human and equine anti-endotoxin antibody-rich serum on Klebsiella pneumoniae. South African Journal of Science 78:92
   [Google Scholar]
7. Pudifin D, L’Hoste I, Duursma J, Gaffin S L. 1985; Opsonisation of gram-negative bacteria by anti-lipopolysaccharide antibodies. Lancet 2:1009–1010
   [Google Scholar]
8. Shenep J L, Barrett F F, Stidham G L, Westenkirscher D F, Flynn P. 1985; Endotoxin liberation during therapy for gram-negative bacterial sepsis. Critical Care Medicine 13:298
   [Google Scholar]
9. Wells M T, Gaffin S L. Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma. Clinical and Experimental Immunology In press
   [Google Scholar]
10. Wells M T, Gaffin S L, Gregory M, Coovadia Y. 1987; Properties of equine anti-lipopolysaccharide hyperimmune plasma: binding to lipopolysaccharide and bactericidal activity against gram-negative bacteria. Journal of Medical Microbiology24 In press
    [Google Scholar]
11. Wilson L A, Spitznagel J K. 1968; Molecular and structural damage to Escherichia coli produced by antibody, complement and lysozyme systems. Journal of Bacteriology 96:1339–1348
    [Google Scholar]